Johnson & Johnson (JNJ) DMA 200 (1968 - 2026)
Johnson & Johnson (JNJ) DMA 200 (1968 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
DMA 200 |
| 1 |
Gsk |
93,699,046.73 Bn |
93,699,041.77 Bn |
7.76 Bn |
49.54 |
| 2 |
Eli Lilly |
1,012.06 Bn |
1,006.77 Bn |
16.22 Bn |
947.65 |
| 3 |
Johnson & Johnson |
560.67 Bn |
538.62 Bn |
15.96 Bn |
213.13 |
| 4 |
AbbVie |
402.20 Bn |
392.85 Bn |
10.78 Bn |
219.96 |
| 5 |
Merck |
298.59 Bn |
292.94 Bn |
12.09 Bn |
103.94 |
| 6 |
Amgen |
188.77 Bn |
176.74 Bn |
5.87 Bn |
329.36 |
| 7 |
Gilead Sciences |
160.22 Bn |
152.49 Bn |
5.52 Bn |
128.92 |
| 8 |
Pfizer |
148.19 Bn |
135.42 Bn |
-1.21 Bn |
25.85 |
| 9 |
Bristol Myers Squibb |
116.72 Bn |
106.26 Bn |
8.07 Bn |
53.21 |
| 10 |
Novartis Ag |
109.78 Bn |
109.09 Bn |
- |
141.18 |
| Date | Value |
|---|
| Jun 5, 2026 |
213.13 |
| Jun 4, 2026 |
212.86 |
| Jun 3, 2026 |
212.60 |
| Jun 2, 2026 |
212.36 |
| Jun 1, 2026 |
212.12 |
| May 29, 2026 |
211.88 |
| May 28, 2026 |
211.61 |
| May 27, 2026 |
211.33 |
| May 26, 2026 |
211.04 |
| May 22, 2026 |
210.74 |
| May 21, 2026 |
210.42 |
| May 20, 2026 |
210.12 |
| May 19, 2026 |
209.83 |
| May 18, 2026 |
209.52 |
| May 15, 2026 |
209.20 |
| May 14, 2026 |
208.90 |
| May 13, 2026 |
208.58 |
| May 12, 2026 |
208.26 |
| May 11, 2026 |
207.98 |
| May 8, 2026 |
207.72 |
